Cargando…

Arterial Thromboembolism in Patients With AF and CHA(2)DS(2)-VASc Score 0-2 With and Without Cancer

BACKGROUND: It is unclear whether newly diagnosed cancer adds to the risk of arterial thromboembolism (ATE) in patients with atrial fibrillation/flutter (AF). This is especially relevant for AF patients with low to intermediate CHA(2)DS(2)-VASc scores in whom the risk-benefit ratios between ATE and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leader, Avi, Mendelson Cohen, Netta, Afek, Shani, Jaschek, Ram, Frajman, Assaf, Itzhaki Ben Zadok, Osnat, Raanani, Pia, Lishner, Michael, Spectre, Galia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Mini-Focus Issue: Bleeding, Thrombosis, and Atrial Fibrillation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152191/ https://www.ncbi.nlm.nih.gov/pubmed/37144112 http://dx.doi.org/10.1016/j.jaccao.2022.08.014

Ejemplares similares

A Picture Is Worth 2,000 Words
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2023)

‘Pill-in-the-pocket’ Oral Anticoagulation Guided by Daily Rhythm Monitoring for Stroke Prevention in Patients with AF: A Systematic Review and Meta-analysis
por: Briosa e Gala, Andre, et al.
Publicado: (2023)

Predictors of stroke or systemic embolism in patients with non-valvular atrial fibrillation with CHA2DS2-VASc score of 0
por: Park, Y, et al.
Publicado: (2023)

Genetic risk and atrial fibrillation in patients with heart failure
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Atrial Fibrillation in Congenital Heart Disease
por: Martín de Miguel, Irene, et al.
Publicado: (2021)

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients
por: Coccina, Francesca, et al.
Publicado: (2020)

Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
por: Linz, Dominik, et al.
Publicado: (2021)

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
por: Andrade, Jason G, et al.
Publicado: (2022)

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation
por: Rosa, Giulio La, et al.
Publicado: (2021)

Atrial fibrillation and heart failure: A contemporary review of current management approaches
por: Lee, Justin Z., et al.
Publicado: (2021)

Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Atrial fibrillation in heart failure: Prime time for ablation!
por: Deisenhofer, Isabel
Publicado: (2021)

Atrial fibrillation in cardiac resynchronization therapy
por: Elliott, Mark K., et al.
Publicado: (2021)

Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021)

Neuromodulatory Approaches for Atrial Fibrillation Ablation
por: Rodríguez-Mañero, Moisés, et al.
Publicado: (2021)

Prevalence of atrial fibrillation and the risk of cardiovascular mortality among hypertensive elderly population in northeast China
por: Xia, Zhenwei, et al.
Publicado: (2022)

Future Directions for Mapping Atrial Fibrillation
por: Zaman, Junaid AB, et al.
Publicado: (2022)

Association Between Left Atrial Appendage Morphology and Function and the Risk of Ischaemic Stroke in Patients with Atrial Fibrillation
por: Dudziñska-Szczerba, Katarzyna, et al.
Publicado: (2022)

Clinical Relevance of Sinus Rhythm Mapping to Quantify Electropathology Related to Atrial Fibrillation
por: van Schie, Mathijs S, et al.
Publicado: (2022)

A Chronicle of Hybrid Atrial Fibrillation Ablation Therapy: From Cox Maze to Convergent
por: Kaba, Riyaz A, et al.
Publicado: (2022)

Prediction of atrial fibrillation in patients with hypertension: A comprehensive comparison of office and ambulatory blood pressure measurements
por: Huang, Pin‐Hsiang, et al.
Publicado: (2022)

Atrial fibrillation and 24‐h ambulatory blood pressure pattern
por: Verberk, Willem J.
Publicado: (2022)

Management of Atrial Fibrillation Using Immunoglobulin Free Light Chains, Novel Biomarkers of Inflammation
por: Matsumori, Akira
Publicado: (2022)

Safety, Efficacy and Prognostic Benefit of Atrial Fibrillation Ablation in Heart Failure with Preserved Ejection Fraction
por: Johner, Nicolas, et al.
Publicado: (2022)

Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities for Neuromodulation for the Management of Atrial Fibrillation
por: Aksu, Tolga, et al.
Publicado: (2023)

Prevalence and prognosis of atrial fibrillation in a hypertensive population: A prospective cohort study
por: Wang, Chang, et al.
Publicado: (2023)

Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies
por: Al-Kaisey, Ahmed M, et al.
Publicado: (2023)

Pulsed Field Ablation for Atrial Fibrillation
por: Schaack, David, et al.
Publicado: (2023)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Percutaneous Left Atrial Appendage Occlusion: What the Practising Physician Should Know
por: Merella, Pierluigi, et al.
Publicado: (2023)

Ablation as First-line Therapy for Atrial Fibrillation
por: Andrade, Jason G
Publicado: (2023)

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism
por: Coleman, Craig I., et al.
Publicado: (2023)

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients
por: Diamond, Akiva, et al.
Publicado: (2023)

Atrial Fibrillation Incidence Associated With Exposure to Anticancer Drugs Used as Monotherapy in Clinical Trials
por: Alexandre, Joachim, et al.
Publicado: (2023)

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023)

Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid Cancer
por: Feldman, Stephanie, et al.
Publicado: (2023)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA (2)DS (2)-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study
por: Lee, Yi, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_llji0lj5c45eijmgblvfiqfrg0